Indication

Sezary disease

Sézary disease, commonly termed Sézary syndrome, is an aggressive, leukemic variant of cutaneous T-cell lymphoma that primarily involves the skin, peripheral blood, and lymphatic system, most frequently presenting in older adults. Read more about Sezary disease

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Sezary disease therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Sezary disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Sezary disease.

Sézary disease, commonly termed Sézary syndrome, is an aggressive, leukemic variant of cutaneous T-cell lymphoma that primarily involves the skin, peripheral blood, and lymphatic system, most frequently presenting in older adults.

Pathophysiologically, the condition is driven by the malignant clonal proliferation of mature CD4+ T helper cells displaying characteristic cerebriform nuclei, known as Sézary cells.

Clinically, it is defined by a triad of generalized, intensely pruritic erythroderma covering the vast majority of the body surface area, significant peripheral lymphadenopathy, and circulating neoplastic T lymphocytes in the peripheral bloodstream.

Personalize your experience

Follow Sezary disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it